Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights [Yahoo! Finance]
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences [Yahoo! Finance]
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences